Amerisource Health Services Recalls NIFEdipine Capsules Due to Foreign Tablets
Amerisource Health Services recalls NIFEdipine 10mg capsules (NDC 68084-022) due to foreign tablets present. Consumers should contact the company for details.
Lower-risk recall
Presence of Foreign Tablets/Capsules
Contact the company
What happened, in plain English
Amerisource Health Services is recalling NIFEdipine 10mg capsules because foreign tablets may be present. This could cause confusion with other medications or incorrect dosing if taken. Read more at govinfonow.com/recall/42292-amerisource-health-services-recalls-nifedipine-capsules-due-to-foreign-tablets.
Source Summary by GovInfoNow · govinfonow.com/recall/42292-amerisource-health-services-recalls-nifedipine-capsules-due-to-foreign-tablets · Updated October 9, 2026 · FDA enforcement record: FDA #D-0144-2017
Cite this page
“Amerisource Health Services Recalls NIFEdipine Capsules Due to Foreign Tablets.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42292-amerisource-health-services-recalls-nifedipine-capsules-due-to-foreign-tablets. Based on FDA recall #D-0144-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0144-2017%22&limit=1).
Why it’s dangerous
Foreign tablets in the capsules could lead to taking the wrong medication or incorrect dosing. This might cause confusion with other medications or unintended side effects.
Who’s affected
People who have the recalled NIFEdipine capsules (100-count carton or individual blister packs) from specific lots. Those taking blood pressure medication are most at risk.
How to tell if you have this one
Check for the NDC codes 68084-022-01 (100-count carton) or 68084-022-11 (individual blister). The capsules were manufactured by Actavis Elizabeth, LLC and distributed by American Health Packaging.
- Brand
Amerisource Health Services- Category
Drug
What to do — step by step
Check Capsule Lot Numbers
Look for lot numbers 155404, 161139, 163060, or 164054, 164809 on the packaging.
How this recall unfolded
Recall timeline
FDA terminated this recall 11 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0144-2017 (October 13, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0144-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.